Skip to main content
Apyx Medical Corp logo

Apyx Medical Corp — Investor Relations & Filings

Ticker · APYX ISIN · US0323472052 LEI · 5299009QZVYUYO082S45 US Manufacturing
Open in API
Filings indexed 969 across all filing types
Latest filing 2015-12-14 Major Shareholding Noti…
Country US United States of America
Listing US APYX

About Apyx Medical Corp

https://apyxmedical.com/

Apyx Medical Corporation is an advanced energy technology company that develops, manufactures, and markets innovative products for surgical and cosmetic markets. The company's proprietary Helium Plasma Platform, which is the foundation for its Renuvion® and J-Plasma® brands, utilizes a unique combination of helium plasma and radiofrequency (RF) energy. These systems are designed to deliver controlled energy for the cutting, coagulation, and ablation of soft tissue, with a primary focus on aesthetic procedures for skin tightening and body contouring. Apyx Medical, formerly Bovie Medical, leverages its expertise in energy-based waveforms to provide transformative solutions for surgeons and their patients.

Recent filings

Filing Released Lang Actions
SC 13G/A
Major Shareholding Notification
2015-12-14 English
FORM 4
Director's Dealing
2015-11-23 English
FORM 10-Q
Interim / Quarterly Report 9M 2015
2015-11-05 English
BOVIE 8-K EARNINGS 9 30 15
Earnings Release Classification · 95% confidence The document is a Form 8-K filing dated November 4, 2015, reporting the results of operations for the third quarter ended September 30, 2015. It includes a press release attached as Exhibit 99.1 that reports the financial results for the quarter. The document explicitly states it is a current report pursuant to the Securities Exchange Act of 1934 and is reporting earnings results. The content is typical of an Earnings Release (ER) as it announces quarterly financial results with key highlights. The document length is 2853 characters, which is short but contains the actual earnings announcement rather than just a notice of report publication. Therefore, it should be classified as an Earnings Release (ER).
2015-11-05 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated October 20, 2015, reporting the entry into a material definitive agreement. It details the acquisition of Bovie Bulgaria EOOD and related management agreements. The content focuses on a significant corporate transaction and agreements rather than financial results, management changes, or other report types. Form 8-K filings are current reports used to announce major events. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit into more specific categories like M&A filings (which would be more detailed merger or acquisition filings), or management changes. The document length is under 5,000 characters and contains detailed information about the agreements, not just an announcement of a report publication. Therefore, the best classification is Regulatory Filings (RNS).
2015-10-23 English
FORM 4
Director's Dealing
2015-10-21 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.